ESR1 and breast cancer: Jia-Wei-Xiao-Yao-San and Shu-Jing-Huo-Xue-Tang significantly improved the overall survival rate of estrogen receptor-positive breast cancer patients and reduced the risk of tamoxifen-induced endometrial cancer [28].